Journal of Clinical Biochemistry and Nutrition
Online ISSN : 1880-5086
Print ISSN : 0912-0009
ISSN-L : 0912-0009
Original Articles
Correlation between vitamin D and cardiovascular disease predictors in overweight and obese Koreans
Misung KimWoori NaCheongmin Sohn
Author information
JOURNAL FREE ACCESS FULL-TEXT HTML

2013 Volume 52 Issue 2 Pages 167-171

Details
Abstract

Although there is evidence that vitamin D deficiency relates to expression of chronic disease, relationship between vitamin D and cardiovascular disease predictors have not been clearly demonstrated in Korean. Our objective was to assess the correlation between vitamin D and the cardiovascular and inflammatory markers in overweight and obese people who had not been exposed to a particular disease. We enrolled 171 healthy adults (159 men and 12 pre-menopausal women) with no history of cardiovascular disease and with a body mass index >23 kg/m2 in this study. In addition, levels of serum vitamin D and concentrations of the inflammatory markers hs-CRP, interleukin-6, and adiponectin were measured. The average age of our study subjects was 48.53 years old, and 64.8% of all male subjects and 91.9% of all female subjects were in the vitamin D deficient status. Serum vitamin D levels showed a positive correlation with age (p<0.05), HDL-cholesterol (p<0.05), and adiponectin (p<0.05) levels. However, there was a negative correlation of vitamin D with triglyceride (p<0.01) and interleukin-6 levels (p<0.05). In addition, even after adjusting for factors that may affect the cardiovascular index (age, sex, body mass index, smoking, and alcohol intake), serum vitamin D levels showed a significant correlation with triglyceride (p<0.05), HDL-cholesterol (p<0.05), and adiponectin (p<0.05) levels. Therefore, the results of this study suggest that vitamin D may be a predictor of cardiovascular disease for overweight and obese people who are likely to be at a risk for cardiovascular disease.

Introduction

In humans, vitamin D is usually provided by food or when 7-dehydrocholesterol in the skin is changed to vitamin D by ultraviolet rays. As Korea is in a geographically advantageous position, as it receives plenty of sunlight for vitamin D synthesis, there was no serious deficiency of vitamin D among Koreans in the past. However, because people in Korea now engage in fewer outdoor activities and use more sunblock, vitamin D deficiency has been increasingly reported. Vitamin D is widely known to act as a hormone that is required for growth and maintenance of the skeleton and for the homeostasis of calcium; in addition, it was recently found to play a role in the control of cell proliferation and differentiation and in immunity.(14)

Vitamin D deficiency is involved in the regulation of blood glucose through its correlation with insulin resistance and beta-cell failure.(5) Additionally, the vitamin D receptor is expressed in immunocytes and has been shown to repress division of cytokine and dendritic cells and stimulate regulator T cells.(68)

The representative cardiovascular disease indicating index CRP is an acute phase reactant produced in liver from stimulation of Interleukin-6 (IL-6), reported as it accelerates inflammation of arteriosclerosis. Adiponectin is negatively related with insulin resistance among type II diabetes mellitus and metabolic syndrome patients, reported as a factor restraining progress of cardiovascular disease with anti-inflammation effect.(912)

This indicates that vitamin D not only has an immunity effect but also controls inflammation. In morbidly obese patients, the serum 25-hydroxyvitamin D [serum 25(OH)D] level is associated with the levels of IL-6, adiponectin,(13) and high-sensitivity C-reactive protein (hs-CRP), cytokines expressed in fat cells.(14) In other words, serum vitamin D deficiency acts as a risk factor that increases inflammatory markers. In addition, vitamin D is related to expression of chronic diseases such as myocardial infarction,(15) diabetes,(5,16,17) and hypertension.(18) At the same time, vitamin D deficiency is reportedly related to the concentration of lipids, which is a risk factor of cardiovascular disease.(19)

Serum 25(OH)D is used as a marker to evaluate the concentration of vitamin D in the human body.(20) In a study conducted with menopausal Korean women, the average serum 25(OH)D level was 12.2–17.6 ng/ml,(2123) while in the 2009 National Nutrition Survey, men aged 19–30 years old had an average serum level of 18.9–19.6 ng/ml and women had a average level of 16.6–17 ng/ml.(24) In addition, the analysis of the 2007–2009 National Nutrition Surveys showed that the average serum 25(OH)D level in men in their 50s was 20 ng/ml.(19) For vitamin D status, Korean studies show that the age levels are lower than the vitamin deficiency threshold level of 20 ng/ml established by the Institute of Medicine.(25) Thus, the vitamin D concentration has been shown to be low. However, studies related to vitamin D levels in Koreans are limited to menopausal women or healthy adults, and there is a lack of research on particular diseases and about people at risk of disease.

Therefore, we conducted this study to investigate the relevance of vitamin D status of overweight and obese adults who are likely to be exposed to chronic disease. We also assessed the lipid status and inflammatory marker levels of our study subjects to verify whether vitamin D was a predictor of cardiovascular disease.(26)

Materials and Methods

Study subjects

From May to July 2011, we enrolled 171 healthy adults (159 men and 12 pre-menopausal women) with no history of cardiovascular disease who visited the hospital for health promotion center and who had a BMI >23 kg/m2. This study was performed after receiving the approval of the Institutional Review Board of Wonkwang University.

Anthropometric and blood pressure measurement

Subjects removed their shoes and, while wearing light clothes, their height and weight were measured using an automatic height–weight measuring instrument (Gtech, Korea). The Inbody 3.0 body composition analyzer (Biospace, Korea) was used to measure BMI, body fat, and body fat percentage. For abdominal circumference, the midpoint between the iliac spine and the lowest limit of the ribs was measured using a tapeline. Blood pressure was recorded by asking the subjects to rest for 10 min by sitting in a comfortable position and then using an automatic blood pressure gauge (Jawon medical, Korea). We also took an average of the systolic and diastolic blood pressures that were measured twice.

Biochemical examination and risk of cardiovascular disease

For blood tests, subjects were asked to fast for at least 12 h, and the blood was centrifuged at 3,000 rpm for 15 min to obtain the serum. Blood glucose, triglyceride, total cholesterol, and HDL-cholesterol levels were measured using an automatic biochemical analyzer BS-220 (Mindray, China). LDL-cholesterol was calculated based on the Friedewald formula {[total cholesterol (mg/dl) – HDL-cholesterol (mg/dl)] – TG (mg/dl)/5}.(27) hs-CRP was analyzed using a latex agglutination test and the Hitachi 7600-110 system (Hitachi, Japan). Serum IL-6 was analyzed with a special IL-6 kit (Bender Med Systems, Austria), and adiponectin was analyzed using a human adiponectin special kit (Adipogen, Korea) and an enzyme-linked immunosorbent assay (ELISA) reader (Molecular Devices, California). Insulin was measured with electrochemiluminescence immunoassay using an electrochemiluminescent autoanalyzer (Modular E170, Germany). The homeostasis model assessment index for insulin resistance (HOMA-IR), a marker for insulin resistance, was calculated as [glucose (mg/dl) × insulin (µU/ml)/405].(28) Serum 25(OH)D was analyzed using 25 OH Vitamin D reagent based on the chemiluminescent immunoassay (CLIA). The risk of cardiovascular disease was analyzed using Framingham risk score.

Statistical analysis

All statistical analyses in this study were performed with the SPSS ver. 12.0. We calculated the mean ± SD, and the difference between the vitamin D deficiency group and the non-vitamin D deficiency group was examined using the t test. The relationship between serum vitamin D concentration and biochemical markers and anthropometric was determined by Pearson’s correlation coefficients. To investigate the effect of vitamin D on triglyceride, HDL-cholesterol, adiponectin, and IL-6 level, we used 5 models for each marker: Model 0 was analyzed without a control variable; Model 1 by controlling age; Model 2 age and sex; Model 3 age, sex, and BMI; Model 4 age, sex, BMI, and smoking; and Model 5 age, sex, BMI, smoking, and alcohol intake. Multiple regression analysis was then performed for these models. Statistical significance was set at p<0.05.

Results

Anthropometric and biochemical examination results of the subjects

The results of anthropometric and biochemical examination for serum vitamin D status are shown in Table 1. The vitamin D deficiency group and non-vitamin D deficiency group were divided based on the 20 ng/ml Institute of Medicine standard. The average age of study subjects was 48.53 years old, and a total of 64.8% of male subjects and 91.7% of female subjects were found to have a vitamin D deficiency. The subjects’ blood tests showed that the average blood glucose level was 104.75 mg/dl, total average cholesterol level was 199.13 mg/dl, average HDL-cholesterol level was 44.25 mg/dl, and average LDL-cholesterol level was 112.22 mg/dl. There was no significant difference between the 2 groups. As for triglyceride, the vitamin D deficiency group had an average level of 180.21 mg/dl, and the non-deficiency group registered an average level of 149.37 mg/dl; thus, there was a significant difference between 2 groups (p<0.01). Analysis of inflammatory markers showed that the average concentration of hs-CRP was 1.86 µg/ml and that of adiponectin was 8.80 µg/ml, and only IL-6 concentration was statistically significantly different between the 2 groups (p<0.05). The IL-6 concentration for the vitamin D deficiency group was 1.73 pg/ml and for the non-deficiency group, this value was 0.81 pg/ ml. The average HOMA-IR value was 5.06, and the Framingham risk score, which indicates the risk of cardiovascular disease, was 8.46 on average. There was no significant difference between the 2 groups.

Table 1 Anthropometrics, biochemical parameters, and inflammation markers in patients with and without vitamin D deficiency
Variables Vitamin D deficiency group (n = 114) Non-vitamin D deficiency group (n = 57) Total (n = 171) t/χ2
Sex
 Men 103 (64.8%) 56 (35.2%) 0.057
 Women 11 (91.7%) 1 (8.3%)
Age (years) 48.01 ± 9.68 49.58 ± 10.57 48.53 ± 9.98 −0.942
Weight (kg) 79.56 ± 10.98 80.26 ± 9.75 79.79 ± 10.56 −0.426
BMI (kg/m2) 27.12 ± 2.91 26.81 ± 2.37 27.02 ± 2.74 0.738
WC (cm) 93.3 ± 7.2 93.59 ± 6.03 93.4 ± 6.81 −0.274
Body fat mass (kg) 21.72 ± 5.29 21.22 ± 3.95 21.55 ± 4.88 0.658
Body fat (%) 27.02 ± 4.33 26.11 ± 2.83 26.72 ± 3.92 1.402
Blood pressure
 SBP (mmHg) 127.09 ± 12.42 128.42 ± 16.47 127.53 ± 13.87 −0.592
 DBP (mmHg) 79.8 ± 9.61 80.98 ± 12.96 80.19 ± 10.82 −0.674
Glucose (mg/dl) 104.68 ± 22.91 104.91 ± 23.48 104.75 ± 23.03 −0.063
Triglyceride (mg/dl) 180.21 ± 75.43 149.37 ± 64.4 169.93 ± 73.22 2.785**
Cholesterol (mg/dl) 200.38 ± 32.65 196.63 ± 37.99 199.13 ± 34.45 0.636
Hdl-Cholesterol (mg/dl) 43.52 ± 9.51 45.69 ± 9.11 44.25 ± 9.41 −1.446
Ldl-Cholesterol (mg/dl) 113.2 ± 27.61 110.29 ± 29.73 112.22 ± 28.28 0.617
HOMA-IR 5.11 ± 6.2 4.95 ± 8.22 5.06 ± 6.91 0.133
hs-CRP (µg/ml) 1.92 ± 2.56 1.74 ± 2.56 1.86 ± 2.55 0.438
Adiponectin (µg /ml) 8.56 ± 3.17 9.27 ± 4.07 8.8 ± 3.5 −1.158
Interleukin-6 (pg/ml) 1.73 ± 2.79 0.81 ± 1.22 1.43 ± 2.42 2.38*
FRS 8.42 ± 7.01 8.56 ± 6.73 8.46 ± 6.89 −0.120
Vitamin D (ng/ml) 13.77 ± 3.52 25.17 ± 3.78 17.57 ± 6.48 −19.478***

Presented values are the mean SD. Significantly different by chi-square test, Significantly different at *p<0.05, **p<0.01, ***p<0.001 by t test.

Correlation between vitamin D, anthropometric, and inflammatory marker

The correlation between serum vitamin D and anthropometric and inflammatory markers is shown in Table 2. In the analysis of correlation between serum vitamin D and age (p<0.05), we found a positive correlation: higher age led to higher vitamin D concentration. There was also a positive correlation between HDL-cholesterol (p<0.05) and adiponectin (p<0.05) levels and vitamin D. A negative correlation was found between vitamin D and triglyceride (p<0.01) and an inverse correlation was seen between the inflammatory marker IL-6 (p<0.05) and vitamin D.

Table 2 Correlation between anthropometric and biochemical parameters and inflammation markers with vitamin D levels
Variable r p
Age (years) 0.152 0.048
Weight (kg) 0.04 0.600
BMI (kg/m2) 0.007 0.923
WC (cm) 0.043 0.578
Body fat mass (kg) −0.040 0.624
Body fat (%) −0.107 0.173
Blood pressure
 SBP (mmHg) 0.083 0.278
 DBP (mmHg) 0.136 0.076
Glucose (mg/dl) 0.045 0.555
Triglyceride (mg/dl) −0.203 0.008
Cholesterol (mg/dl) −0.022 0.778
Ldl-cholesterol (mg/dl) −0.028 0.719
Hdl-cholesterol (mg/dl) 0.179 0.019
HOMA-IR 0.023 0.768
hs-CRP (µg/ml) −0.029 0.707
Adiponectin (µg/ml) 0.163 0.033
Interleukin-6 (pg/ml) −0.152 0.047
FRS −0.071 0.379

Relationship between serum vitamin D concentration and biochemical markers and anthropometric was determined by Pearson’s correlation coefficients.

Multiple regression analysis of vitamin D and relevant factors

The multiple regression analysis result for serum vitamin D, triglyceride, HDL-cholesterol, adiponectin, and IL-6 is shown in Table 3. Even after controlling for age, sex, BMI, smoking, and alcohol intake, serum vitamin D showed an effect on levels of triglyceride (p<0.05), HDL-cholesterol (p<0.05) and adiponectin (p<0.05).

Table 3 Correlation between vitamin D and different factors studied at baseline and after adjustment for age, sex, BMI, smoking, and alcohol intake
Variable B2 Significance
Triglyceride (mg/dl)
 Model 0 −1.173 0.031
 Model 1 −0.188 0.018
 Model 2 −0.191 0.015
 Model 3 −0.189 0.016
 Model 4 −0.160 0.044
 Model 5 −0.158 0.047
Hdl-cholesterol (mg/dl)
 Model 0 0.177 0.028
 Model 1 0.178 0.025
 Model 2 0.174 0.027
 Model 3 0.173 0.027
 Model 4 0.175 0.024
 Model 5 0.164 0.040
Adiponectin (µg/ml)
 Model 0 0.163 0.042
 Model 1 0.146 0.068
 Model 2 0.162 0.040
 Model 3 0.178 0.026
 Model 4 0.185 0.018
 Model 5 0.183 0.019
Interleukin-6 (pg/ml)
 Model 0 −0.150 0.062
 Model 1 −0.123 0.131
 Model 2 −0.109 0.178
 Model 3 −0.126 0.122
 Model 4 −0.107 0.189
 Model 5 −0.094 0.253

Model 0, at baseline; Model 1, after adjustment for age; Model 2, after adjustment for age and sex; Model 3, after adjustment for age, sex and BMI; Model 4, after adjustment for age, sex, BMI and smoking; Model 5, after adjustment for age, sex, BMI, smoking, and alcohol intake.

Discussion

This study investigated the correlation between the vitamin D status and cardiovascular disease indicators and inflammatory markers in overweight and obese adults with no history of cardiovascular disease. The results showed a correlation between serum vitamin D and HDL-cholesterol, triglyceride, and adiponectin levels.

Also, in this study, it is found 65% of men with over BMI 23 kg/m2 have vitamin D deficiency, and 91.7% when it comes to women with same condition, showing higher degree compared to non-vitamin deficient group. The result of previous studies studying vitamin D intakes shows that 92% of menopausal women have vitamin D deficiency,(21,22) and 90.6% when it comes to adults over 50s in Korean. Also, Korea National Health and Nutrition Examination Survey shows 56% of metabolic syndrome patients have vitamin D deficiency.(29)

In this study, the BMI and percentage of body fat of the vitamin D deficiency group showed higher tendency than that of the non-deficiency group, even though statistically insignificant. In a previous study on the correlation between serum 25(OH)D levels and body fat, it was found that serum 25(OH)D and body fat had a negative correlation in obese women.(30) In addition, a study by Worstman showed that higher BMI leads to a lower vitamin D concentration.(31) It has also been reported that obese patients are more likely to lack serum vitamin D because vitamin D is a fat soluble vitamin that is not easily eluted from adipose tissue once absorbed; therefore, obese people lack vitamin D and vitamin D deficiency aggravates obesity.(32) However, in the current study percentage of body fat and BMI did not correlate with vitamin D concentration. This lack of relationship may due to subjects’ selection including overweight and obese.

The US Third National Health and Nutrition Examination Survey (1988–1994) found that a higher serum 25(OH)D concentration leads to a lower risk of diabetes.(5) Additionally, the intake of vitamin D and calcium is known to reduce the risk of type 2 diabetes.(16) Similarly, a study conducted with Chinese people found that higher serum 25(OH)D concentrations were correlated with lower insulin and HOMA-IR levels in a group with BMI of 24 kg/m2,(33) indicating the correlation between vitamin D and glycemic control. However, in this study, we did not find a correlation between HOMA-IR and serum 25(OH)D levels; we believe that this is because our study subjects were overweight adults with no particular disease and who maintained normal blood glucose levels. Therefore, there may not have been any relation to HOMA-IR.

US study results analyzing National Health and Nutrition Examination Survey (NHANES) shows blood lipid levels including triglyceride and total cholesterol are the risk element of cardiovascular disease.(34) Also, the study conducted by Giovannucci and others suggest low 25(OH)D degree is an element increasing risk of myocardial infarction, indicating relation of vitamin D with manifestation of cardiovascular disorders.(15) In a study assessing the risk factors for cardiovascular disease and vitamin D, lower vitamin D concentrations were found to lead to higher blood cholesterol and LDL-cholesterol concentration.(35) In addition, Chacko et al.(36) conducted a study with menopausal women, which showed a correlation between serum 25(OH)D levels and triglyceride. However, although the present study differed from previous studies in that our subjects were not patients with a particular disease such as metabolic syndrome, and menopause, we found a negative correlation of 25(OH)D concentration with triglyceride levels and positive correlation of 25(OH)D concentration with HDL-cholesterol levels.

In a study targeting Korean male workers has found a group with vitamin D deficiency has higher triglyceride, the risk element of cardiovascular disorders, than a group with non-deficiency, and this study has found the same difference between two groups. This shows deficiency of vitamin D has relation with triglyceride, the risk element of cardiovascular disorders.(37)

In this study, when factors related with cardiovascular disease including age, sex, Body Mass Index (BMI), smoking, and drinking are not controlled, triglyceride and vitamin D have the strongest impact, and they have low impact when the factors are controlled, showing there is a negative correlation. This can be considered as a result of sensitive reaction of triglyceride, compared to other indices, to smoking, drinking, and diet, and it may cause by eating habit of Koreans, which is high levels of carbohydrate intakes.(38) Therefore, we believe it is necessary for overweight adults who have a high risk of cardiovascular disease to maintain normal levels of blood 25(OH)D as well as triglyceride and HDL-cholesterol; this is important in preventing cardiovascular disease due to vitamin D deficiency.

It is reported abdominal fat caused by excessive fat accumulation has relation with immunity, inflammation, and infection due to cytokine secreted by adipose tissue.(39) It is known vitamin D affects inflammation reaction, having relation with gene expression of IL-6, the inflammatory markers.(40) In study with obesity subjects, it is found CRP had negative correlation between 25(OH)D and IL-6.(14) In our study, the objects are overweighed, it is found vitamin D has negative correlation between IL-6, having same result with study objecting obese people. It shows low vitamin D degree can be an element increasing IL-6, the inflammatory markers in overweight people without disease. In patients with diseases such as type 2 diabetes and cardiovascular disease, low adiponectin concentration has been reported.(41) However, but, Gannagé-Yared(42) suggested that higher 25(OH)D concentrations increased adiponectin levels and that vitamin D increased adiponectin levels. In this study, adiponectin had a positive correlation with vitamin D levels even after controlling for age, BMI, sex, smoking, alcohol intake confirming the activity of vitamin D as an independent predictor of cardiovascular disease.

This study demonstrated a correlation between vitamin D and serum triglyceride, HDL-cholesterol, and inflammatory markers in overweight and obese Korean adults; in addition, adiponectin was found to be an independent predictor of cardiovascular disease. Therefore, to prevent cardiovascular disease, we suggest that overweight people lose weight and engage in more outdoor activities. This will help maintain normal serum vitamin D levels and vitamin D synthesis by sunlight. Overweight people also need to take a sufficient quantity of vitamin D in the form of food supplements or via food.

The limitation of this study was that it did not compare differences between overweight people and healthy adults. Nevertheless, the study confirmed a correlation between vitamin D and inflammatory markers in Korean. Because this study did not take into account vitamin D taken from food, future studies will need to include both dietary analysis and biochemical analysis.

Abbreviations

25(OH)D; 25-hydroxyvitamin D, BMI; body mass index, DBP; diastolic blood pressure, FRS; framingham risk score, HDL-Cholesterol; high-density lipoprotein cholesterol, HOMA-IR; homeostasis model assessment of insulin resistance, hs-CRP; high-sensitivity C-reactive protein, IL-6; interleukin-6, LDL-Cholesterol; low-density lipoprotein cholesterol, SBP; systolic blood pressure, WC; waist circumference

Conflict of Interest

No potential conflicts of interest were disclosed.

References
  • 1   Walters  MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13: 719–764.
  • 2   Lemire  JM. Immunomodulatory actions of 1,25-dihydroxyvitamin D3. J Steroid Biochem Mol Biol 1995; 53: 599–602.
  • 3   Lips  P. Vitamin D deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 2001; 22: 477–501.
  • 4   Holick  MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004; 80 (6 Suppl): 1678S–1688S.
  • 5   Scragg  R,  Sowers  M,  Bell  C;Third National Health and Nutrition Examination Survey. Serum 25-hydroxyvitamin D, diabetes, and ethnicity in the Third National Health and Nutrition Examination Survey. Diabetes Care 2004; 27: 2813–2818.
  • 6   Mauricio  D,  Mandrup-Poulsen  T,  Nerup  J. Vitamin D analogues in insulin-dependent diabetes mellitus and other autoimmune diseases: a therapeutic perspective. Diabetes Metab Rev 1996; 12: 57–68.
  • 7   Zella  JB,  DeLuca  HF. Vitamin D and autoimmune diabetes. J Cell Biochem 2003; 88: 216–222.
  • 8   Overbergh  L,  Decallonne  B,  Valckx  D, et al. Identification and immune regulation of 25-hydroxyvitamin D-1-alpha-hydroxylase in murine macrophages. Clin Exp Immunol 2000; 120: 139–146.
  • 9   Pasceri  V,  Willerson  JT,  Yeh  ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation 2000; 102: 2165–2168.
  • 10   Gabay  C,  Kushner  I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448–454.
  • 11   Lara-Castro  C,  Fu  Y,  Chung  BH,  Garvey  WT. Adiponectin and the metabolic syndrome: mechanisms mediating risk for metabolic and cardiovascular disease. Curr Opin Lipidol 2007; 18: 263–270.
  • 12   Snehalatha  C,  Mukesh  B,  Simon  M,  Viswanathan  V,  Haffner  SM,  Ramachandran  A. Plasma adiponectin is an independent predictor of type 2 diabetes in Asian indians. Diabetes Care 2003; 26: 3226–3229.
  • 13   Arita  Y,  Kihara  S,  Ouchi  N, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999; 257: 79–83.
  • 14   Bellia  A,  Garcovich  C,  D’Adamo  M, et al. Serum 25-hydroxyvitamin D levels are inversely associated with systemic inflammation in severe obese subjects. Intern Emerg Med 2011. DOI: 10.1007/s11739-011-0559-x
  • 15   Giovannucci  E,  Liu  Y,  Hollis  BW,  Rimm  EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Arch Intern Med 2008; 168: 1174–1180.
  • 16   Pittas  AG,  Dawson-Hughes  B,  Li  T, et al. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006; 29: 650–656.
  • 17   Roth  CL,  Elfers  C,  Kratz  M,  Hoofnagle  AN. Vitamin D deficiency in obese children and its relationship to insulin resistance adipokines. J Obes 2011. DOI: 10.1155/2011/495101.
  • 18   Forman  JP,  Giovannucci  E,  Holmes  MD, et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063–1069.
  • 19   Park  S,  Lee  BK. Vitamin D deficiency is an independent risk factor for cardiovascular disease in Koreans aged ≥50 years: results from the Korean National Health and Nutrition Examination Survey. Nutr Res Pract 2012; 6: 162–168.
  • 20   Holick  MF. The use and interpretation of assays for vitamin D and its metabolites. J Nutr 1990; 120 Suppl 11: 1464–1469.
  • 21   Lee  MK,  Yoon  BK,  Chung  HY,  Park  HM. The Serum Vitamin D nutritional status and its relationship with skeletal status in Korean postmenopausal women. Korean J Obstet Gynecol 2011; 54: 241–246.
  • 22   Park  HM,  Kim  JG,  Choi  WH,  Lim  SK,  Kim  GS. The Vitamin D nutritional status of postmenopausal women in Korea. Korean J Bone Metab 2003; 10: 47–55.
  • 23   Lips  P,  Hosking  D,  Lippuner  K,  Norquist  JM,  Wehren  L,  Maalouf  G,  Ragi-Eis  S,  Chandler  J. The prevalence of vitamin D inadequacy amongst women with osteoporosis: an international epidemiological investigation. J Intern Med 2006; 260: 245–254.
  • 24  Ministry of Health and Welfare, Korea Centers for Disease Control and Prevention. Korea Health Statistics 2009: Korea National Health and Nutrition Examination Survey (KNHANESIV-3). Cheongwon: Ministry of Health and Welfare, 2009; 526.
  • 25  Institute of Medicine (IOM). Dietary reference intakes for calcium and Vitamin D. Washington, DC: The National Academies Press, 2011; 13–14.
  • 26   Liu  E,  Meigs  JB,  Pittas  AG, et al. Plasma 25-hydroxyvitamin D is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009; 139: 329–334.
  • 27   Friedewald  WT,  Levy  RI,  Fredrickson  DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499–502.
  • 28   Matthews  DR,  Hosker  JP,  Rudenski  AS,  Naylor  BA,  Treacher  DF,  Turner  RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412–419.
  • 29   Kim  S,  Lim  J,  Kye  S,  Joung  H. Association between vitamin D status and metabolic syndrome risk among Korean population: based on the Korean National Health and Nutrition Examination Survey IV-2, 2008. Diabetes Res Clin Pract 2012; 96: 230–236.
  • 30   Vilarrasa  N,  Maravall  J,  Estepa  A, et al. Low 25-hydroxyvitamin D concentrations in obese women: their clinical significance and relationship with anthropometric and body composition variables. J Endocrinol Invest 2007; 30: 653–658.
  • 31   Wortsman  J,  Matsuoka  LY,  Chen  TC,  Lu  Z,  Holick  MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000; 72: 690–693.
  • 32   Rosenstreich  SJ,  Rich  C,  Volwiler  W. Deposition in and release of vitamin D3 from body fat: evidence for a storage site in the rat. J Clin Invest 1971; 50: 679–687.
  • 33   Lu  L,  Yu  Z,  Pan  A, et al. Plasma 25-hydroxyvitamin D concentration and metabolic syndrome among middle-aged and elderly Chinese individuals. Diabetes Care 2009; 32: 1278–1283.
  • 34   Martins  D,  Wolf  M,  Pan  D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med 2007; 167: 1159–1165.
  • 35   Chiu  KC,  Chu  A,  Go  VL,  Saad  MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79: 820–825.
  • 36   Chacko  SA,  Song  Y,  Manson  JE, et al. Serum 25-hydroxyvitamin D concentrations in relation to cardiometabolic risk factors and metabolic syndrome in postmenopausal women. Am J Clin Nutr 2011; 94: 209–217.
  • 37   Park  SH,  K  Yw,  Chae  CH, et al. The Relationship of serum vitamin D levels and the Framingham Risk Score among male workers in the manufacturing Sector. Korean J Occup Environ Med 2012; 24: 115–123.
  • 38   Kim  M,  Kim  J,  Bae  W, et al. Relationship between nutrients intakes, dietary quality, and serum concentrations of inflammatory markers in metabolic syndrome patients. Korean J Community Nutr 2011; 16: 51–61.
  • 39   Stefanyk  LE,  Dyck  DJ. The interaction between adipokines, diet and exercise on muscle insulin sensitivity. Curr Opin Clin Nutr Metab Care 2010; 13: 255–259.
  • 40   Jablonski  KL,  Chonchol  M,  Pierce  GL,  Walker  AE,  Seals  DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension 2011; 57: 63–69.
  • 41   Hotta  K,  Funahashi  T,  Arita  Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000; 20: 1595–1599.
  • 42   Gannagé-Yared  MH,  Chedid  R,  Khalife  S,  Azzi  E,  Zoghbi  F,  Halaby  G. Vitamin D in relation to metabolic risk factors, insulin sensitivity and adiponectin in a young Middle-Eastern population. Eur J Endocrinol 2009; 160: 965–971.
 
© 2013 JCBN
feedback
Top